TRIP (57) VNET (46) SIFY (52) CEVA (35) ⌘ Pro Terminal →

HealthStream Inc. (HSTM) — RQD Stock Rating Cockpit

$33.80 +0.21% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

HealthStream Inc. (HSTM) carries a Roarable Rating of C+ (Hold) with 66/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

ROARABLE C+ • HOLD / WATCH Cap $1.03B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERHOLD / WATCH • C+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C · Rk B

Each axis scored 0–20

12M PRICE TARGET CONE+3.6% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for HSTM)Realized 20D OHLCV Swing Band: ±5.7%

RSI-14 MOMENTUMBULLISH MOMENTUM

60.130 Oversold · 70 Hot

ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)

3.80>3.0 Fortress Safe

PIOTROSKI F-SCORESOLID CORE (5–6)

5 / 99-Pt Accounting

52-WEEK LASER RANGE89% OF RANGE

L: $20$33.80H: $36

1. Money & Cash Health● MIXED

Are profits real cash in the bank?

Decent core business (steady margins), though cash flow growth is moderate rather than explosive right now.

Factor Grade: CRQD 13 / 20

2. Big Money & Insiders● NEUTRAL

Are whales & executives buying or selling?

Big funds and company insiders are mostly holding steady without aggressive buying or panic selling.

Factor Grade: C-RQD 24 / 40

3. Hidden Risks & Market Weather● ALL CLEAR

SEC fine-print scan & interest-rate fit

Clean SEC fine-print check with low hidden accounting risk and favorable interest-rate weather.

Factor Grade: BRQD 29 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

JEV AI Jury Split (Battleground) on HSTM

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

NEUTRAL (65)

5.0% ROIC with 42.0% gross margin and 5.77% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

NEUTRAL (65)

Altman-Z 4.20 and Piotroski 5/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

BULLISH (67)

24/40 institutional & smart-money positioning score with 16/20 macro alignment.

Bull Case: Why Buyers Like HSTM

✓Established market leader in Technology with deep daily trading liquidity.

Bear Case: What Could Go Wrong

!Priced at 56x earnings—high expectations leave less room for a lukewarm quarter.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (HSTM Tape Review)

✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
✓Forensic Red-Light accounting & dilution traps to review on your watchlist
✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

HSTM // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +62.81%▲ ASCENDING CHANNEL

2026-10-30O $33.86H $34.04L $33.17C $33.80VOL 151.6K

RES: $35.90SUP: $30.27SMA50: $30.94SMA200: $25.58

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

HSTM Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 HSTM Butterfly Map → + Track HSTM →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

39.7%/yr Implied 5Y Growth

vs. +4.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on HSTM today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for HSTM. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for HSTM today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (HSTM)

Technology Rank #162 of 714 ⚔️ TRIP vs HSTM Full Matrix →

1. Head-to-Head Technology Peer Comparison (HSTM vs. TRIP, VNET, SIFY, CEVA)

Industry: Computer Software: Programming Data Processing (72 Tracked Issuers)

Across 714 tracked Technology securities in the Roarable RQD universe, HealthStream Inc. (HSTM) ranks #162 by composite RQD confidence (66/100, grade C+) and #350 by equity capitalization ($1.03B). Within this direct 5-issuer industry benchmark cohort, TRIP leads on earnings valuation at 27.0x trailing P/E, while VNET leads on capital efficiency and profitability with 85.0% ROIC and — gross margin. HSTM currently leads its immediate peer cohort in composite quantitative strength at 66/100 (C+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
HSTM ACTIVE HealthStream Inc.	C+	66/100	56.4x	—	5.0%	+0.21%	$1.03B	Benchmark Subject
TRIP TripAdvisor Inc.	D+	57/100	27.0x	92.3%	13.0%	+3.13%	$1.08B	/trip-vs-hstm →
VNET VNET Group Inc.	D	46/100	—	—	85.0%	-9.16%	$959.9M	/vnet-vs-hstm →
SIFY Sify Technologies Limited	D+	52/100	—	—	—	+0.40%	$914.8M	/sify-vs-hstm →
CEVA CEVA Inc.	D-	35/100	—	87.1%	-3.0%	-0.68%	$905.2M	/ceva-vs-hstm →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001095565

In its most recent audited fiscal period (FY2025, filed 2025-12-31), HealthStream Inc. (HSTM) reported GAAP revenue of $304.1M (+4.3% vs. FY2024 revenue of $291.6M , and +9.0% cumulative change since FY2023) , GAAP net income of $18.3M, operating cash flow of $63.3M, and free cash flow of $59.6M (+6.0% YoY). On the balance sheet, HSTM closed FY2025 with $520.4M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 5/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$304.1M	$18.3M	$63.3M	$59.6M	$520.4M	—
FY2024 (FY)	2024-12-31	$291.6M	$20.0M	$57.7M	$56.3M	$510.8M	—
FY2023 (FY)	2023-12-31	$279.1M	$15.2M	$64.0M	$64.0M	—	—

3. HSTM Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is HSTM stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, HealthStream Inc. (NASDAQ: HSTM) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 66/100 at a spot price of $33.80 (+0.21% 1D, market cap $1.03B). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 13/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 16/20, and SEC Balance-Sheet Forensics 11/20. Across 714 tracked Technology issuers, HSTM ranks #162 in composite RQD confidence.

How does HSTM compare to TRIP and VNET in the Technology sector?

Within the Technology sector (Computer Software: Programming Data Processing), HSTM carries a Roarable C+ (66/100 RQD), trailing P/E of 56.4x, gross margin of —, and ROIC of 5.0%. By comparison, TRIP (TripAdvisor Inc.) holds a D+ grade (57/100 RQD, P/E 27.0x, ROIC 13.0%, cap $1.08B) and VNET (VNET Group Inc.) posts a D grade (46/100 RQD, P/E N/A, ROIC 85.0%, cap $959.9M). Among the 5-stock peer group, TRIP leads on earnings multiple (27.0x) while VNET leads on capital efficiency (85.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for HSTM?

Per HSTM's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001095565), HealthStream Inc. generated $304.1M in revenue (+4.3% YoY), $18.3M in net income, and $59.6M in free cash flow against $520.4M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Priced at 56x earnings—high expectations leave less room for a lukewarm quarter.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is HSTM trading relative to its 50-day, 200-day, and 52-week technical levels?

HSTM last traded at $33.80 (+0.21% on volume of 129,800 shares), positioning the stock +9.24% above its 50-day simple moving average ($30.94) and +32.13% above its 200-day simple moving average ($25.58). Across its 52-week range of $19.50 to $35.61, HSTM sits at the 88.8% percentile with a 14-day RSI of 60.1 (BULLISH MOMENTUM) and an implied next-earnings move of ±5.7% ($31.87 to $35.73).

HSTM Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell HSTM stock right now?

HealthStream Inc. (HSTM) currently earns a Roarable Rating of C+ (Hold — HOLD) with 66/100 RQD Confidence. Solid steady margins (5% return on capital), mixed timing at 56x P/E—hold if owned, no rush to chase.

What is HSTM's 12-month price target and RQD AI Jury consensus?

HSTM's 12-month base price target is $35.02 (range $27.32 to $41.32), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Direct Sub-Reports: HSTM RQD Cockpit HSTM 12M Forecast HSTM Earnings & Move HSTM Dividends & DRIP HSTM Insiders & 13F HSTM Whale Options HSTM Profit Sankey HSTM News & Why